Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Detalles Bibliográficos
Main Authors: Olliaro, P, Kuesel, A, Halleux, C, Sullivan, M, Reeder, J
Formato: Journal article
Idioma:English
Publicado: Public Library of Science 2018
Descripción
Summary:

Títulos similares